Bayer has started a phase 2a trial of an antibody that it hopes could provide a targeted, potentially disease-modifying ...

The Bayer Pharma AG logo is seen on April 03, 2025 in Berlin, Germany. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma ...

FRANKFURT (Reuters) - Bayer said its menopausal relief drug eased hot flashes and improved sleep in two late-stage trials, much-needed good news for the German group's pharmaceuticals unit that is ...

An experimental Bayer AG drug successfully alleviated hot flashes and other disturbances associated with menopause in two studies, clearing a path for a medicine that Bayer says could become a ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the use case for the menopause treatment expected to launch as early as this ...

Werner Baumann, CEO of Leverkusen, Germany-based Bayer, on Wednesday shared his thoughts on rising drug costs, his company’s own drug pricing system and President Donald Trump in an interview with ...

FRANKFURT (Reuters) -Bayer said on Tuesday that it would request regulatory approval for its menopause drug after the daily pill was shown to ease hot flashes in a third late-stage trial, providing ...

Largely on the basis of the strong competitive advantages of the healthcare group and to a lesser extent the crop science business, we believe Bayer has created a wide economic moat. Also, the past ...